© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings

Health and Biotech

Top Section/Ad

Top Section/Ad

Most recent

Equity

Qiagen grabbed 'opportunistic window' to sell $750m CB

qiagen-alamy-010925.jpg
Arthur Bautzer, September 01, 2025
Equity
Brainlab sets price range for €400m IPO as vol stays low
Arthur Bautzer, June 23, 2025
Equity
Galderma shareholders sell increased Sfr1.86bn block at tightest discount yet
Arthur Bautzer, May 28, 2025
Syndicated Loans
PolyPeptide Group increases revolver to €151m for growth
Jennifer Law, May 27, 2025
Corporate Bonds
Novo Nordisk prints €6bn after CEO departs
Mike Turner, May 20, 2025
Equity
GC1902 Deal Cartoon Redcare.jpg
More convertibles could follow Redcare after Easter
DocMorris announces Sfr200m rights issue expected in May
Arthur Bautzer, April 10, 2025
Equity
redcare-alamy-100425
Redcare Pharmacy issues €300m convertible before shock tariff reverse
Stock drops 17% in highly volatile market
Arthur Bautzer, April 09, 2025
Follow-ons and Rights issues
Torstensson, Staffan (ADDvise) from co media gallery 8Apr25 575x375.jpg
ADDvise completes rights issue after 81% take-up
Deal follows steep share price fall
Arthur Bautzer, April 08, 2025
Equity
ophtalmology-alamy-030425
Clínica Baviera block sold hours before US tariff news
Deal was extensively wallcrossed
Arthur Bautzer, April 03, 2025
More articles/Ad

More articles/Ad

More articles

Load More